Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › California › Mountain View
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Mountain View, CA keessatti
Qorannoo 21 Kansara Qara'a Non-Small Cell f Mountain View fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · Miili 5 fagaatti
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · Miili 5 fagaatti
- Stanford Cancer Institute Palo Alto, Palo Alto · Miili 5 fagaatti
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- Stanford University, Stanford · Miili 5 fagaatti
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- Stanford University, Palo Alto · Miili 5 fagaatti
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Namoota walitti qabaa jiraSadarkaa 2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
- Stanford Hospital and Clinics, Stanford · Miili 5 fagaatti
- Stanford Hospital Investigational Drug Services, Stanford · Miili 5 fagaatti
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University Medical Center - Neurology, Stanford · Miili 5 fagaatti
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Palo Alto Medical Foundation Research Center, Palo Alto · Miili 5 fagaatti
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University Medical Center, Stanford · Miili 5 fagaatti
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University Medical Center, Palo Alto · Miili 5 fagaatti
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Palo Alto · Miili 5 fagaatti
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University - Stanford Cancer Institute, Stanford · Miili 5 fagaatti
A Study of LY4175408 in Participants With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Stanford Medicine Cancer Center, Stanford · Miili 5 fagaatti
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University, Stanford · Miili 5 fagaatti
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Women's Cancer Center, Palo Alto · Miili 5 fagaatti
Engagement of Veterans With Lung Cancer
Namoota walitti qabaa jira
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · Miili 5 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Stanford · Miili 5 fagaatti
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Stanford · Miili 5 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Mountain View keessatti
- Saree (Gosoota Hunda)Qorannoo 40
- Saree OljooQorannoo 26
- Kansara MetastatikiiQorannoo 25
- Leukemia Myeloidii HamaaQorannoo 19
- Kansarii OvariiQorannoo 19
- Dhibee Spektiraamii AutisimiiQorannoo 17
- Dhibee QaraQorannoo 17
- Kansarii ProstateQorannoo 15
- Cufama OnneeQorannoo 15
- AutismQorannoo 13
- Leukemia Lymphoblasticii HamaaQorannoo 13
- Kansarii ColorectalQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.